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Dendritic cell Migration to skin-
Draining lymph nodes is controlled 
by Dermatan sulfate and Determines 
adaptive immunity Magnitude
Reza Nadafi1, Jasper J. Koning1‡, Henrike Veninga1‡, Xanthi N. Stachtea2, Tanja Konijn1, 
Antonie Zwiers1, Anders Malmström2, Joke M. M. den Haan1, Reina E. Mebius1,  
Marco Maccarana2 and Rogier M. Reijmers1*†
1 Department of Molecular Cell Biology and Immunology, VU University Medical Center, Cancer Center Amsterdam, 
Amsterdam, Netherlands, 2 Department of Experimental Medical Science, Lund University, Lund, Sweden
For full activation of naïve adaptive lymphocytes in skin-draining lymph nodes (LNs), 
presentation of peptide:MHC complexes by LN-resident and skin-derived dendritic cells 
(DCs) that encountered antigens (Ags) is an absolute prerequisite. To get to the nearest 
draining LN upon intradermal immunization, DCs need to migrate from the infection site 
to the afferent lymphatics, which can only be reached by traversing a collagen-dense 
network located in the dermis of the skin through the activity of proteolytic enzymes. 
Here, we show that mice with altered collagen fibrillogenesis resulting in thicker colla-
gen fibers in the skin display a reduced DC migration to the draining LN upon immune 
challenge. Consequently, the initiation of the cellular and humoral immune response 
was diminished. Ag-specific CD8+ and CD4+ T cells as well as Ag-specific germinal 
center B cells and serum immunoglobulin levels were significantly decreased. Hence, 
we postulate that alterations to the production of extracellular matrix, as seen in various 
connective tissue disorders, may in the end affect the qualitative outcome of adaptive 
immunity.
Keywords: skin–draining lymph node, adaptive immunity, Dse, dendritic cells, dermatan sulfate epimerase, 
collagen, antigen, ehlers–Danlos syndrome
inTrODUcTiOn
Lymph nodes (LNs) are strategically located secondary lymphoid organs that drain nearly all tissues 
of the body, including the skin as the largest organ, to collect foreign soluble and particulate antigens 
(Ags) through a lymphatic vasculature (1, 2). The collection of Ags is essential for a controlled and 
rapid initiation of a robust and Ag-specific adaptive immune response (2–4). Ag-containing lymph 
will flow via the afferent vessels into the sinuses and a collagen-rich conduit system of the draining 
LN, produced by lymphoid stromal cells (5–7). LN-resident dendritic cells (DCs) sample the con-
duits and sinuses for Ags and present these as peptide:MHC complexes for initial activation of naïve 
T cells (1, 2). Next, newly arriving tissue-resident DCs sequentially present peptide:MHC complexes 
to Ag-primed naïve T cells, essential for full activation and successive proliferation. Importantly, 
when migration of distant DCs was prevented upon rapid removal of the injection site, activation of 
T cells was significantly diminished and the cellular immunity severely hampered (1, 2).
Abbreviations: CS/DS, chondroitin/dermatan sulfate; Dse/Dsel, dermatan sulfate epimerase 1/2; DC, dendritic cell; ECM, 
extracellular matrix; GC, germinal center; GAG, glycosaminoglycan; KO, knockout; LN, lymph node; WT, wild-type.
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To reach the afferent lymphatics, DCs from the skin need 
to pass a barrier in the dermis, consisting of a dense but highly 
organized and balanced network of collagens, which requires the 
obligatory activity of metalloproteinases (8). Interestingly, when 
the collagen content in the skin was reduced by 50%, which was 
found in mice deficient for secreted protein acidic and rich in 
cysteine (Sparc), DCs displayed an accelerated emigration from 
the skin resulting in an abnormally rapid T  cell activation (9). 
These findings support a model in which the composition and 
density of the dermal extracellular matrix (ECM) determines the 
efficiency of DC emigration and subsequent immune activation 
in skin-draining LNs (sdLNs).
Notably, collagen fibrillogenesis is strictly controlled by 
many ECM proteins, including small leucine-rich proteoglycans 
that form essential interfibrillar bridges through chondroitin/
dermatan sulfate (CS/DS) glycosaminoglycans (GAGs) attached 
to a core protein (10, 11). To execute their biological functions, 
CS/DS GAGs undergo crucial and extensive modification by 
Golgi apparatus-located biosynthetic enzymes (12). Of these 
enzymes, DS-epimerase 1 in close conjunction with DS-4-O-
sulfotransferase 1 (D4st1 or Chst14) are key in the transforma-
tion of CS to hybrid CS/DS chains (13). Downregulation or 
loss of either enzyme changes the composition of the CS/DS 
GAGs, affecting biological functions (12). Remarkably, next to 
DS-epimerase 1, a second epimerase exists, DS-epimerase 2, 
which has overlapping functions; however, these biosynthetic 
enzymes have been shown to display striking tissue-specific 
distribution. Whereas DS-epimerase 1 is the main epimerase in 
most tissues of the body including the skin (14), DS-epimerase 2 
is most prominently present in the brain (15).
Although both epimerases are ubiquitously expressed, each 
isoform specifically contributes to spatially distinct CS/DS 
GAGs. As a consequence, mice only lacking DS-epimerase 1 
display an altered collagen structure in the skin, which could 
not be compensated for by DS-epimerase 2 (14). Similarly, this 
non-redundancy has recently been observed in humans with a 
homozygous DSE missense mutation (16). These patients were 
classified as a subtype of Ehlers–Danlos syndrome, a connective 
tissue disorder. Importantly, the Ehlers–Danlos syndromes rep-
resent a heterogeneous group of diseases, which are well known 
for their fragility of the soft connective tissues, including the skin. 
Therefore, we set out to study the effect of DS epimerase-1 (Dse) 
deficiency, in mice, on the adaptive immune response in sdLNs 
initiated after intradermal immunization.
MaTerials anD MeThODs
Mice
All mice used in this study were maintained on a mixed C57BL/6-
129/SvJ genetic background as described previously (14). Mice 
heterozygous for DS-epimerase 1 (Dse+/-) were crossed and all 
wild-type (WT; Dse+/+; hereafter DseWT) and knockout (Dse-/-; 
hereafter DseKO) littermates were used. All experiments were 
initiated with mice between 7–10 weeks of age. Experiments were 
approved by the VU University Ethical Committee according 
to Dutch law (MCB-14-19) or the Ethical Committee of Lund 
University according to Swedish law and national guidelines 
(M27-16).
Fluorescent Tracers
EαGFP was a kind gift from Dr. Marc Jenkins (17) and FITC-
conjugated OVA was from Thermo Fisher Scientific. Mice received 
an intradermal injection in the ankle. Five minutes or 40 h after 
injection, sdLNs were harvested, fixed as described (18), or used 
as single-cell suspensions after enzymatic digestion (19). ER-TR7 
staining surrounding the high endothelial venules (HEVs) was 
surface-masked using Imaris Software (Bitplane, version 8.02 or 
higher). Within this mask, EαGFP mean intensity was measured.
Quantification of Dcs in skin
Skin biopsies were pretreated (20) and processed as described 
(21). In short, for quantification of DCs in skin, ears of mice were 
fixed for 20 min in ice-cold acetone, washed with PBS, dehydrated 
with methanol series (20, 40, 60, 80, and 100%) twice, and subse-
quently rehydrated. Ears were blocked with blocking Fc-receptors 
using antibody clone 2.4G2 o/n at 4°C, and subsequently incu-
bated with directly labeled primary antibody against MHCII 
(clone M5/114, Alexa Fluor 647 labeled) for 4 days in PBS, 4°C, 
rotating. After three washing steps in PBS, ears were embedded in 
1.5% low-melting agarose for easy handling. Samples were dehy-
drated with methanol series (20, 40, 60, 80, and 100%) twice, and 
overnight incubated in 1:1 methanol:Benzyl-Alcohol/Benzyl-
Benzoate (BABB; 1:2, both Sigma). Next morning, all solutions 
were replaced with BABB and stored in the dark until acquisition. 
Acquisition was performed using the Ultramicroscope (La Vision 
BioTec, Bielefeld). Images were analyzed using Imaris Software. 
DCs were detected using spots detection function. To calculate 
the minimal distance between the next spot, we used the Spots to 
Spots closest distance Xtension, which calculates and displays the 
distance to the closest neighbor of the Spots objects to determine 
DC density in the skin.
Dc Migration assays
For the Transwell migration assay, DCs were isolated from 
spleens, using Magnisort CD11c positive selection kit (Invitrogen) 
according to manufacturer’s protocol. After purification, 50 × 103 
cells were placed in the upper compartment of a 5.0  µm pore 
size Transwell (Corning Costar Corp., Corning, NY, USA) and 
allowed to migrate for 2 h in the absence (medium only) or pres-
ence of 250 ng/mL recombinant mouse CCL21 (R&D systems) 
to the lower compartment. For the dermal sheet DC migration 
assay, ears were split into dorsal and ventral halves as described 
before (20, 22), and dorsal skin part was allowed to float on cul-
ture medium. Migration of cells was permitted for 40 h either or 
not in the presence of 250 ng/mL rmCCL21 (R&D systems). For 
both migration assays, total migrated cells were quantified using 
an LSR-Fortessa X20 (BD Biosciences) flow cytometer.
immunization and Tissue isolation
Mice received an intradermal injection in the ankle of 100 µg OVA 
(CalBiochem) with adjuvant in 50 µL PBS (23). Blood was taken 
at indicated time points to determine serum immunoglobulins. 
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Isolated spleen and LNs were snap frozen in Tissue Tek OCT 
(Sakura Finetek) for immunohistochemistry, or used as single 
cells for culture and/or flow cytometry after enzymatic digestion.
immunofluorescence staining
Staining was performed as described (24). mAbs used were 
anti-CD11c-FITC (clone M17/4), anti-CD11c (clone N418), 
anti-IFNγ-APC (clone XMG1.2), B220-AF647 (clone RA3-6B2), anti- 
CD4-PE (clone GK1.5), anti-CD8-PE (clone 53-6.7), anti- 
GL7-biotin (clone GL.7), anti-CD38-PE (clone 90), goat 
anti-rat-AF555 all from eBioscience (ThermoFisher Scientific, 
MA, USA), anti-IgD-AF647 (clone 11-26c, BioLegend, CA, USA), 
anti-ER-TR7 (clone ER-TR7), anti-CD45-AF647 (clone MP33), 
and anti-MHCII-AF647 obtained from laboratory hybridomas. 
Biotin was detected using streptavadin-PerCP-Cy5.5 (eBiosci-
ence). Tissue was analyzed using a Zeiss fluorescent microscope 
(AXIO Imager.D2, Carl Zeiss) or Leica DM6000, captured 
with ZEN 2 pro software (version 2.0.0.0, Carl Zeiss) or Leica 
software and processed with Adobe Photoshop and Illustrator 
CS6.
OVa-specific elisa
ELISA was performed as described (25). In brief, high-binding 
96-well plates (Nunc Maxisorp) were coated with 5 µg/mL OVA 
(Sigma-Aldrich) and blocked with 2% bovine serum albumin 
(BSA) in PBS. Serial dilutions of serum in 1% BSA/PBS were 
incubated for 2  h at RT. Detection of OVA-specific antibod-
ies was achieved by using polyclonal rabbit-anti mouse total 
Ig-HRP (1:2,000; Dako, P0161) in 1% BSA/PBS for 1 h at RT and 
subsequent incubation with 3,3′,5,5′-tetramethylbenzidine as 
a liquid substrate at RT for a maximum of 8 min. Absorbance 
was measured at 450 nm minus the absorbance at 570 nm. OVA-
specific antibody titers were calculated as area under the curve, 
normalized to a standard, and shown as arbitrary units (a.u.).
T cell restimulation
Splenocytes were isolated 10  days after immunization and 
restimulated in 200 µL per well (1 × 106 cells/mL) with MHCII 
restricted OVA262–276 peptide (100 µg/mL) for 16 h or with MHCI 
restricted OVA257–264 peptide (0.1 µg/mL) for 5 h at 37°C, of which 
the final 5  h of both stimuli in the presence of GolgiPlug (BD 
Biosciences).
Flow cytometry
Cell staining was performed with mAbs as listed above after 
blocking Fc–receptors with antibody clone 2.4G2. OVA-specific 
germinal center (GC) B cells were identified using 5 µg/mL OVA-
488 (Invitrogen). IFNγ was detected as described (25). Cells were 
acquired on a Cyan ADP (Beckman Coulter) or LSR-Fortessa 
X20 (BD Biosciences) flow cytometer, and analyzed with Flowjo 
package 10 (Tree Star). Live/dead cells were distinguished using 
Live-Dead-eFluor780 (eBioscience).
statistical analysis
Significance was determined by GraphPad Prism performing a 
two-tailed unpaired Student’s t-test.
resUlTs
Dse-Deficient sdlns Display normal 
cellular Organization and ag collection
Impaired Ag drainage or lower cell numbers in sdLNs could affect 
the outcome of an adaptive immune response initiated upon 
intradermal immunization (1, 2). For this reason, we first set out 
to determine the amount of immune cells present in homeostatic 
LNs of adult DS-epimerase 1 (Dse) deficient mice and compared 
these with LNs of age-matched WT littermates. Quantification 
of single-cell suspensions by flow cytometry of sdLNs revealed 
equal total cell numbers, including similar amounts of total DCs, 
T  cells, and B  cells, all immune cell subsets critically involved 
in the initiation of an adaptive immune response (Figure 1A). 
In addition, fluorescent immunohistochemistry analysis showed 
a comparable cellular architecture as to WT LNs, with B  cells 
organized in follicles lined by subcapsular sinus macrophages, and 
DCs similarly dispersed throughout the T cell zone (Figure 1B). 
Finally, we performed short-term (5  min) fluorescent tracer 
experiments to study the Ag drainage capacity of Dse deficient 
sdLNs. Notably, we observed that Ags ranging from 32 to 47 kDa 
readily saturated the conduits and sinuses quickly reaching 
the HEVs upon entering of the subcapsular sinus (Figure 1C). 
Indeed, as exemplified by EαGFP (Figure 1D), the intradermally 
injected fluorescent tracer completely co-localized with ER-TR7 
expression, a marker for the conduits produced by lymphoid 
stromal cells (26) and surrounding HEVs. Quantification of the 
average EαGFP intensity within the conduits revealed no differ-
ence between WT and Dse-deficient mice (Figure 1D).
Together, these results demonstrate that sdLNs of Dse-deficient 
mice are equally capable of rapidly collecting and distributing 
soluble Ags via the subcapsular sinus toward the HEVs after 
intradermal administration and that comparable architecture 
and cell numbers permits equivalent Ag exposure to allow the 
initiation of an adaptive immune response.
In Vivo Dc Migration from skin to Draining 
lns is impaired in Dse-Deficient Mice
Antigens reach the draining LN not only as soluble particles 
(5, 27, 28), but a large part is also taken up by DCs in the skin 
for processing, transport, and presentation to LN-resident T cells 
(2, 28). This sequential peptide:MHC presentation of Ags to 
naïve T  cells by DCs is essential for maximal activation of the 
adaptive immune response initiated in the Ag-draining LN (1, 2). 
Since we previously found an increase in collagen fiber diameter 
in the skin of Dse-deficient mice (14) and because skin-derived 
DCs need to degrade this dense collagen network in the dermis 
to reach the afferent lymphatics (8), we determined the in vivo 
migration efficiency of CD11c+ skin-derived DCs to the nearest 
draining LN (20). For this purpose, we performed intradermal 
injections in the ankle of mice with an Ag consisting of amino 
acids 46–74 of I–Edα MHCII subunit fused to a green fluorescent 
protein (EαGFP), which allowed for easy tracing of Ag-bearing 
skin-derived DCs (2). Importantly, it was previously shown that 
after 24  h, cells that were EαGFP+ within draining LNs were 
almost exclusively CD11c+ MHCII(hi) expressing skin-derived 
FigUre 1 | Cellular organization and antigen collection capability of skin-draining lymph nodes (sdLNs). (a) Total sdLN cells, CD11c+ dendritic cells (DCs), CD3+ 
T cells, and CD19+ B cells of wildtype (DseWT) and Dse deficient (DseKO) mice were quantified upon isolation of single cells from homeostatic adult sdLNs 
(mean ± SEM; n = 4–7 mice; average of four sdLNs per mouse is shown). (B) sdLN tissue sections of untreated adult DseWT and DseKO mice stained for B cells 
(B220, green), DCs (CD11c, blue), and subcapsular sinus macrophages (CD169, red). (c) Distribution of EαGFP (left panels) and FITC-conjugated OVA (middle 
panels), 5 min after intradermal injection, in the subcapsular sinus (red arrows), the conduit system (yellow arrow heads), and surrounding the high endothelial 
venules (red arrow heads) of sdLNs. Right panels are an enlargement of white boxes (representation of n = 4 mice, 2 sdLNs/mouse analyzed). (D) EαGFP 
co-localization with ER-TR7 (right images) in DseWT and DseKO sdLNs after intradermal EαGFP injection compared to the contralateral side (left images)  
of the same mice. Bar diagram represents the average fluorescence intensity (arbitrary units; a.u.) of EαGFP that co-localizes with ER-TR7 expression.
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FigUre 2 | In vivo migration of dermal dendritic cells (DCs) to skin-draining lymph nodes (sdLNs). sdLNs of wildtype (DseWT) and Dse-deficient (DseKO) mice were 
isolated 40 h after intradermal injection with EαGFP in the ankle. (a) Absolute number of total sdLN cells (left panel) and CD11c+ DCs (right panel, sdLN DCs) 
recovered from the sdLNs 40 h after intradermal injection. (B) Absolute number of total MHCII(hi) DCs (left panel) and MHCII(hi)EαGFP+ DCs (right panel) found 
within the total CD11c+ DC population of the sdLNs after intradermal injection [for (a,B) bars are mean ± SD; n = 3 mice, 2 sdLNs/mouse, *p ≤ 0.05, **p ≤ 0.01]. 
(c) Gating strategy used to identify CD11c+ MHCII(hi)EαGFP+ migratory DCs in the sdLNs, as presented in (a,B).
FigUre 3 | Skin distribution and ex vivo intrinsic migration potential of 
dendritic cells (DCs). (a) MHCII (green) expressing DC density in skin of 
wildtype (DseWT) and Dse-deficient (DseKO) mice. Three and four 
distances (in micrometers) are shown. The shortest distance is used (e.g., 
19.6 µm) as average distance between MHCII expressing DCs and shown 
in the bar diagram (n = 3 mice, ≥40 cells/mouse analyzed throughout the 
whole tissue). (B) Total CD11c+ DCs that migrated from dermal sheets of 
ears (dorsal part) upon mechanical disruption obtained from DseWT and 
DseKO mice. Cells were allowed to migrate for 40 h either or not in the 
presence of CCL21 (250 ng/mL). (c) DCs were isolated from spleen and 
allowed to migrate for 2 h in the absence (control) or presence of 250 ng/
mL CCL21 in a Transwell system. (B) Bars indicate mean ± SEM (n = 3 
mice, one ear per condition, *p ≤ 0.05). (c) Bars indicate mean ± SEM of 
4–6 experiments performed in triplicate (each dot represents an individual 
mouse, *p ≤ 0.05).
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DCs (2, 29). Forty hours after intradermal injection of this fluo-
rescent tracer the total cell number, and the absolute amount of 
CD11c+ DCs of the skin-draining (popliteal) LN were similar 
(Figure 2A). However, quantification of the MHCII(hi) express-
ing migratory CD11c+ EαGFP+ DCs that had taken up Ag from 
the skin showed that more than 50% fewer Ag+ cells reached 
the sdLNs in Dse-deficient mice (Figures 2B,C). Remarkably, not 
only Ag+ DCs were affected in their migration to Dse-deficient 
sdLNs, also the total number of CD11c+ MHCII(hi) DCs were 
reduced to half of the population observed in WT littermates, 
irrespective of Ag uptake (Figures 2B,C). For these MHCII(hi) 
skin-derived DCs, it is known that they continually migrate 
from the skin at a low rate to the draining LN and that upon 
intradermal immunization the migratory numbers significantly 
increase (2, 30).
In summary, these findings imply that in Dse deficient mice 
both basal as well as induced migration of CD11c+ MHCII(hi) 
DCs from the skin to the draining LN is reduced.
Ex Vivo Basal and ccl21-induced 
Migration of Dse-Deficient Dcs  
is Unaffected
To determine whether the difference in CD11c+ MHCII(hi)
EαGFP+ cells that reached the draining LNs could be explained 
by reduced presence of DCs in the skin of Dse-deficient mice, 
we analyzed homeostatic skin of adult WT and Dse-deficient 
littermates. By applying 3D ultra-microscopy of whole mount 
ears, we could clearly detect that the distribution of skin-resident 
MHCII expressing DCs in Dse-deficient mice was comparable to 
WT littermate controls throughout the whole tissue (Figure 3A).
Next, to address if these DCs were equally able to migrate 
from their location in the skin, we collected uninflamed ears 
and separated the dorsal from the ventral halves, exposing the 
dermis using forceps (20, 22). We specifically used the ears, as 
the dermis of the mouse ear skin is very thin, and prone to injury, 
FigUre 4 | IFNγ production of OVA-specific CD4+ and CD8+ T cells. Total splenocytes of wildtype (DseWT) and Dse-deficient (DseKO) mice were isolated 10 days 
after intradermal OVA injection in the ankle, and subsequently stimulated with MHC class II restricted OVA262–276 peptide or with MHC class I restricted OVA257–264 
peptide to induce the production of IFNγ in CD4+ T cells (a) and CD8+ T cells (B), respectively, and shown as percentage of IFNγ-producing over total CD4+ or 
CD8+ T cells (mean ± SEM; n = 7 mice; *p ≤ 0.05). (c) Gating strategy of CD4+ and CD8+ IFNγ-producing CD3+ CD11a+T cells (a,B).
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which upon mechanical separation of the two halves results in the 
disruption of the local microenvironment, including the collagen 
network (31). Therefore, in contrast to other parts of the body 
skin, including the ankle, this skin tissue can be readily used to 
monitor basal and chemokine-induced ex vivo migration without 
the barrier function of the ECM. For measuring DC emigration 
capacity, we transferred the dorsal halves, dermis down, to a cul-
ture dish, and allowed the cells to migrate for 40 h either or not in 
the presence of 250 ng/mL CCL21, a potent chemoattractant and 
promoter of transmigration of DCs across lymphatic endothelia 
(32). Using this specific assay, we found that upon exposure of 
the dermis, the ex vivo migratory capacity with a disturbed ECM 
barrier is similar for skin-residing DCs of Dse deficient and WT 
mice, irrespective of the presence of CCL21, as comparable cell 
numbers were acquired (Figure 3B).
Finally, to further support equal migratory functionality, we 
purified DCs obtained from Dse-deficient and WT animals. 
Upon isolation, the DCs were allowed to migrate in vitro, toward 
a gradient of 250 ng/mL soluble CCL21 or medium only for 2 h, 
using a Transwell migration assay. Importantly, in line with the ex 
vivo dermal sheet migration assay, both basal and CCL21-induced 
migration of Dse-deficient DCs was unaffected (Figure 3C).
As such, these results highly suggest that the observed in vivo 
impaired migration of skin-derived DCs to the draining LNs in 
Dse-deficient mice is neither a result of DC seeding density in the 
skin, nor a reflection of intrinsic defects in the migration ability 
of the DCs themselves, but rather an effect of an altered ECM 
composition in the dermis of the intact skin.
loss of Dse results in a reduced cellular 
immune response
Since we identified a more than 50% reduction in the amount 
of Ag-bearing DCs in the sdLNs upon intradermal injection 
(Figure  2B), we hypothesized that naïve T  cell activation in 
sdLNs would elicit a lower response in Dse-deficient mice. For 
this purpose, we challenged mice with an intradermal injection 
of OVA, together with an inflammation inducing adjuvant, to 
study the Ag-specific cellular immune response. Ten days after 
immunization, mice were sacrificed and spleens (33) were col-
lected to examine OVA-specific T  cell responses by means of 
restimulation with OVA peptides (Figures 4A–C). Using either 
OVA262–276 peptide for CD4+ T  cells or OVA257–264 peptide for 
CD8+ T  cells (25), we were able to identify gamma interferon 
(IFNγ) production in OVA-specific CD11a+ T cells (Figure 4C). 
For Dse-deficient mice, we found that the percentage of CD4+ 
T  cells producing IFNγ was only half of what we observed in 
control mice (Figures  4A,C), while the CD8+ T  cell response 
was even diminished by more than 70% (Figures 4B,C).
This severe reduction in T  cell activation implies that 
DS-epimerase 1 is required for controlling the efficiency of the 
T cell responses by regulating the amount of dermal DCs that can 
reach the sdLNs and present peptide:MHC complexes for further 
activation of initially primed T cells.
Dse Deficient Mice have Fewer ag-
specific gc B cells and lower  
antibody Titers
For B  cells to become Ag-specific antibody-producing plasma 
cells, they need to specifically recognize their Ag, and upon B cell 
receptor engagement, they require cognate T cell help to initiate 
a GC reaction (34). These cognate T cells are derived from the 
peptide:MHC specific CD4+ T cell pool, of which the amount 
of IFNγ-producing cells was severely reduced (Figures  4A,C). 
In line with these findings, we found that the absolute number 
of Ag-specific GC B  cells, 10  days after intradermal OVA 
injection, was also more than 50% lower in Dse-deficient mice 
(Figures 5A,B). Since we found normal drainage of soluble Ag 
into the draining LN (Figures  1C,D), this illustrates that the 
FigUre 5 | OVA-specific germinal center (GC) B cells and serum immunoglobulin levels. (a) Control non-draining lymph nodes (LNs) and OVA-draining LNs of 
wildtype (DseWT) and Dse-deficient (DseKO) mice were isolated 10 days after intradermal OVA challenge and analyzed for OVA-specific GC B cells (mean ± SEM; 
n = 6 mice, 2 LNs/mouse; *p ≤ 0.05). (B) Percentage of B220+ B cells measured in OVA-draining LNs 10 days after intradermal OVA injection. (c) Gating strategy 
used to determine OVA-specific GC B cells. (D) OVA-specific serum immunoglobulins (arbitrary units, a.u.) measured by ELISA before (naïve) and 10 days after 
immunization (mean ± SEM; n = 10 mice, of two independent experiments; **p ≤ 0.01).
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limited amount of cognate helper CD4+ T cells (Figures 4A,C) 
impedes the induction and recruitment of normal quantities of 
GC B cells into the GC reaction resulting from fierce competition 
for peptide:MHC complexes (34, 35). As a consequence, OVA-
specific immunoglobulin titers in Dse deficient mice measured at 
day 10 after immunization were much lower (<55%) compared to 
WT littermates, despite the detection of equal numbers of B220+ 
B cells in OVA-draining LNs (Figures 5C,D). This further sup-
ports the notion that fewer Ag-specific B cells have been recruited 
into the GC reaction, leading to less antibody-producing plasma 
cells and a significant reduction of OVA-specific serum immuno-
globulin levels in Dse-deficient animals (34, 35).
Taken together, our results support an important and novel 
role for DS-epimerase 1 in regulating the normal release of 
Ag-bearing DCs from the dermis of the skin, through modifica-
tion of the ECM, in particular collagen fibrillogenesis (14, 36). 
Accordingly, naïve T and B cells were inadequately activated in 
the sdLN, leading to an inefficient commencement of the sub-
sequent Ag-specific adaptive immune response, triggered upon 
intradermal immunization.
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DiscUssiOn
Upon infection, a vast array of Ags intrude the host and reach 
the nearest collecting LNs through different mechanisms. While 
a proportion of Ag quickly travels via lymphatic vessels into the 
lymphatic sinuses and conduits of a draining LN (5, 27, 28), 
to be acquired by local DCs, a large part is taken up by DCs at 
the site of infection for transport to the same downstream LN 
(1, 2). The latter process takes more time, because DCs located 
in the skin need to traverse and degrade a collagen-rich layer in 
the dermis to reach the afferent lymphatics (8, 30). In this way, 
Ag encounters distinct DC subsets that in two waves present 
peptide:MHC complexes to T  cells in the draining LN. This 
well-timed combination has been demonstrated to be essential 
for rapid, proper, and long-lasting immunity (1, 2). Notably, 
hybrid CS/DS chains critically participate in the collagen fibril 
maturation (36), and in its absence, alters the skin collagen 
structure (14). Here, by using mice deficient for DS-epimerase 
1, an essential enzyme in CS/DS biosynthesis (13), we provide 
novel evidence that suboptimal synchronization of these Ag 
waves, caused by altered collagen fibrillogenesis resulting in 
thicker fibers in the dermis, has severe consequences for the 
initiation of an efficient adaptive immune response triggered 
in the skin.
As a result of Dse ablation, we found a consistent impairment 
of in  vivo DC emigration from the skin toward the draining 
LN, while cell number and architecture were unaffected allow-
ing normal distribution of equal amounts of Ag throughout 
the LN sinuses and conduit system, reaching the HEVs. More 
specifically, our findings suggest that the basal low migration of 
MHCII(hi)CD11c+ migratory DCs from the skin was reduced, 
independent of inflammation. This was further supported 
by our observation that once fluorescent Ag was injected, it 
resulted in fewer Ag+ skin-derived DCs in the draining LNs 
approximately 2 days after introduction into the dermis. This 
implies that MHCII(hi) migratory (Ag-loaded) DCs in the 
dermis encounter a physical barrier that is harder to breach 
in the absence of DS-epimerase 1 (14), leading to diminished 
peptide:MHC presentation in the sdLN upon Ag exposure. 
Although a disrupted role for Ag presentation in the sdLN 
by Langerhans cells (LCs) in our model cannot be entirely 
excluded, we argue that the effect is marginal because it was 
suggested that dermal DCs have an Ag uptake advantage, as 
intradermal injection leads to Ag deposition in the dermis (2). 
Nevertheless, the impaired migration of CD11c+ MHCII(hi) 
DCs from the skin, which includes LCs, had a major impact on 
the functional outcome of the Ag-specific immune response. 
Indeed, after intradermal immunization with OVA in combina-
tion with an inflammation inducing adjuvant, we found that 
both the cellular and humoral part were affected, resulting in 
lower numbers of Ag-specific T  cells and GC B  cells, and a 
decrease in protective serum antibody levels.
Notably, DCs have been shown to express DS-epimerase 1 to 
some extent, but D4st1 transcripts were undetectable (6). This is 
important, since D4st1 can only generate CS/DS hybrid struc-
tures in conjunction with DS-epimerase 1, and vice versa. These 
structures are most often observed on decorin and biglycan, two 
important proteoglycans. Likewise, these multifunctional CS/DS 
proteoglycans are absent in DCs (6), while highly expressed by 
fibroblasts from the skin (7, 14). Overall, this suggests that DCs 
do not possess a suitable biosynthetic machinery to argue a DC 
intrinsic defect in Dse-deficient mice (37). Rather the results seem 
to reflect that altered collagen fibers in the skin are underlying 
the reduced DC migration that we observe here. Indeed, our data 
show that the ex vivo and in vitro basal and CCL21–dependent 
migratory capacity of DCs was unaffected by the loss of Dse 
expression, but in the absence of an ECM network with normal 
integrity. Altogether, this underscores our notion that the bar-
rier function of intact skin is critically involved in the regulated 
release of migratory DCs through DS-epimerase 1-dependent 
modulation of the ECM in the dermis.
It should be pointed out that our findings are in support with 
results obtained in Sparc-deficient mice, where the amount of 
collagen fibers in the skin was reduced without affecting the size 
in diameter. This eventually led to an accelerated DC migration 
from the skin and a subsequent rapid priming and full activation 
of naïve T cells in the draining LN (9). Together with our results, 
these data demonstrate that spatiotemporal regulation of the 
composition and tightness of the ECM can have significant con-
sequences for the adaptive immune response initiated in the skin, 
which calls for more in-depth analysis of the ECM in controlling 
the onset of immune processes. This could likely have a broader 
effect on immune reactions originating in other tissues consisting 
of balanced ECM contents, including the lung, for which we have 
shown high epimerase activity that is lost upon DS-epimerase 1 
disruption (14).
In summary, our data show that a change in structure of 
CS/DS GAGs in the dermis is detrimental for the induction of 
an efficient adaptive immune response in sdLNs in mice. We 
previously demonstrated that the presence of DS-epimerase 1 
is necessary for the formation of collagen fibrils of a consistent 
and essential size in diameter (14), which is controlled by CS/
DS GAGs (10, 13), and that dysregulation of the CS/DS biosyn-
thetic machinery crucially affects migration of Ag-loaded DCs 
residing in the skin. Our findings could be clinically important, 
as humans that lack DSE or CHST14 expression have been 
identified (16, 38–41). These patients suffer from a connective 
tissue disorder known as musculocontractural Ehlers–Danlos 
syndrome subtype, which includes skin hyperextensibility as a 
result of abnormal distribution and deposition of collagen fib-
ers in the dermis of the skin (16, 41, 42). Hence, based on our 
results, vaccination strategy in patients with connective tissue 
disorders involving the skin ECM might need reconsideration, 
and susceptibility to opportunistic skin infections should be 
explored in more detail.
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